Filing Details
- Accession Number:
- 0001127602-11-010409
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-03-16 17:47:43
- Reporting Period:
- 2011-03-15
- Filing Date:
- 2011-03-16
- Accepted Time:
- 2011-03-16 17:47:43
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1073431 | Life Technologies Corp | LIFE | Biological Products, (No Disgnostic Substances) (2836) | 330373077 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1124164 | J Arnold Levine | 5791 Van Allen Way Carlsbad CA 92008 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2011-03-15 | 6,958 | $32.17 | 8,039 | No | 4 | M | Direct | |
Common Stock | Disposition | 2011-03-15 | 6,958 | $50.25 | 1,081 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options | Disposition | 2011-03-15 | 6,958 | $0.00 | 6,958 | $32.17 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2008-11-21 | 2011-10-18 | No | 4 | M | Direct |
Footnotes
- Options exercised from Grant #00010306 pursuant to 10b5-1 Trading Plan
- Sale of common stock from exercise of Grant #00010306 Pursuant to 10b5-1 Trading Plan
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.06 to $50.36, inclusive. The reporting person undertakes to provide to Life Technologies Corporation, any security holder of Life Technologies Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth